Betamethasone Sodium Phosphate and Betamethasone Acetate

Product NDC
0517-0791
11-digit product format
005170791
Labeler code
0517
Product ID
0517-0791_0be90d39-6559-4241-b8be-c1ee438be718
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Betamethasone Sodium Phosphate and Betamethasone Acetate
Dosage form
INJECTION, SUSPENSION
Route
INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR
Labeler
American Regent, Inc.
Application
ANDA090747
Marketing category
ANDA
Marketing start
2019-11-01
Substance
BETAMETHASONE ACETATE; BETAMETHASONE SODIUM PHOSPHATE
Active strength
3; 3 mg/mL; mg/mL
Pharmacologic classes
Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Corticosteroid [EPC]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
Betamethasone Sodium Phosphate and Betamethasone Acetate
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
BETAMETHASONE ACETATE3 mg/mL
BETAMETHASONE SODIUM PHOSPHATE3 mg/mL

Harmonized Identifiers#

Field, Values table
FieldValues
UniiTI05AO53L7, 7BK02SCL3W
Rxcui578803

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
dde7b902-54a1-627e-12f1-9e6d244ab88cProduct name420250317
726062af-1135-4707-a1d7-57256991bbf9Product name220250226
69b49899-11cf-4f7e-bd0a-7dc93b27311bProduct name320250130
bbdc14c7-d940-43b5-a2f7-36c425991f3cProduct name120240320
0a2fcc35-464b-9ec2-a622-753662cdd48cProduct name320240216
6f762601-17ef-4321-8f47-77783d3c4d8bProduct name320231116
1dbefad7-ab34-69c3-e51a-e7148aa38f70Product name520220921
7fea2046-07a9-4bb6-9409-828ac6f1f6dfProduct name120210201
f059f1a2-0e64-4839-9a7f-42687c91a44bProduct name120201007
4ea9e4b5-b452-48ad-9b25-b9a4d403405dProduct name120160310
f31c883b-7ebf-1c60-f3b6-4ba41e8ff7a6Product name220151106
19c71a3d-ed9c-166b-a7e5-38c250c35631Product name120140508
4f07db9b-3707-3e2c-05b5-d7852ba808c4Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0517-0791-01Betamethasone Sodium Phosphate and Betamethasone Acetate1 in 1 CARTONINJECTION, SUSPENSION13
0517-0791-01Betamethasone Sodium Phosphate and Betamethasone Acetate5 mL in 1 VIAL, MULTI-DOSEINJECTION, SUSPENSION53

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0517-0791-01ML - Milliliter0517-0791fc62a58b-5a13-465d-b618-8bb879816d9512020-03-10

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
0517-0791BETAMETHASONE SODIUM PHOSPHATE AND BETAMETHASONE ACETATE INJECTION, SUSPENSION [AMERICAN REGENT, INC.]2Current NDC, Legacy NDC, 2 package rows20221203_335f17e7-069d-456c-8507-26253692f2ee.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
578803betamethasone sodium phosphate / betamethasone acetate 6 MG/ML Injectable SuspensionPSN335f17e7-069d-456c-8507-26253692f2ee3
578803betamethasone 3 MG/ML / betamethasone acetate 3 MG/ML Injectable SuspensionSCD335f17e7-069d-456c-8507-26253692f2ee3
578803betamethasone 3 MG/ML (as betamethasone sodium phosphate) / betamethasone acetate 3 MG/ML Injectable SuspensionSY335f17e7-069d-456c-8507-26253692f2ee3

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
0517-0791-01005170791011 VIAL, MULTI-DOSE in 1 CARTON (0517-0791-01) / 5 mL in 1 VIAL, MULTI-DOSE2019-11-010000-00-00NoNoCurrent